Study about effect of agressive uric acid decrease treatment on left ventricular hypertrophy
Phase 3
- Conditions
- eftVentricular Hypertrophy
- Registration Number
- JPRN-UMIN000014113
- Lead Sponsor
- Research office of Study of effect of UA decrease treatment on LVH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who has cardiomyopathy or valvular disease 2) Patients who has coronary artery diasese 3) Paitents who has congenital heart disease 4) Patients who has severe hepatic or renal diasese 5) Patinets who is taking diuretics 6) Patients who is allergic to Febxiostat 7) Pregnant or mother who is providing breast milk 8) Patients who doctor in charge diagnosed to be inappropriate for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method eft Ventricular Mass
- Secondary Outcome Measures
Name Time Method Cardiovascular event